Global atrial fibrillation devices market share from EP ablation catheters is anticipated to register a 14.4% CAGR over the coming years as the devices are witnessing high adoption in minimally invasive surgeries worldwide. EP ablation catheters are widely used in the treatment of paroxysmal, persistent, and permanent atrial fibrillation conditions to yield successful outcomes. A surge in R&D investments for the development of these products will enhance the availability of atrial fibrillation ablation devices.

Emergence of sophisticated healthcare infrastructure and the consistent deployment of advanced technological solutions will accelerate the demand for atrial fibrillation devices through the coming years. Several reimbursement policies pertaining to healthcare have been regulated across developed and developing countries.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3165

Hospitals dominated the atrial fibrillation devices market and contributed to more than USD 2,483.4 million in annual remuneration in 2018. This can be attributed to the continous preference of consumers towards hospitals in comparison to other healthcare amenities besides the growth in the number of multi-specialty hospitals.

Atrial fibrillation treatment procedures are excessively opted for across hospital settings, fostering the demand for the devices. Furthermore, there is a noticeable rise in the number of hospital admissions to tend to cardiovascular and other related illnesses across the developed economies.

U.S. atrial fibrillation devices market is pegged to strike a CAGR of 13.9% over the next few years owing to the incorporation of the latest technologies in surgeries as well as robust capabilities of consumers to spend on healthcare in the region. The rising awareness of atrial fibrillation systems will significantly drive the regional device installation.

Global atrial fibrillation devices market is highly concentrated and boasts of the presence of eminent players including Microport Scientific Corporation, Abbott Laboratories, Johnson and Johnson, Boston Scientific Corp, and Atricure Inc., amongst others. These companies have been brainstorming into introducing novel innovations in the field while being involved in strategic measures such as acquisitions, partnerships, product differentiation, and facility expansion.

Request for customization @ https://www.decresearch.com/roc/3165

Partial Chapter of the Table of Content

Charts & Figures

FIG. 1    Aatrial fibrillation devices market segmentation

FIG. 2    Global atrial fibrillation devices market, 2014 – 2025 (USD Million)

FIG. 3    Growth potential analysis, by product

FIG. 4    Growth potential analysis, by end-use

FIG. 5    North America atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

FIG. 6    Europe atrial fibrillation catheter ablation procedures, by region, 2014 -  2025

FIG. 7    North Europe atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

FIG. 8    South Europe atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

FIG. 9    East Europe atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

FIG. 10  West Europe atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

FIG. 11  Asia Pacific atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

FIG. 12  Latin America atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

FIG. 13  MEA atrial fibrillation catheter ablation procedures, by country, 2014 -  2025

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/atrial-fibrillation-devices-market